Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia

References

• Petrides PE, Siegel F. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles. Blood Cells Mol Dis 2006;36:379–384. doi:10.1016/j.bcmd.2005.12.031.
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka HM. The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Curr Hematol Malig Rep 2009;4:33–40. doi:10.1007/s11899-009-0005-6.
   PubMedGoogle Scholar
• Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 2019;94:133–143. doi:10.1002/ajh.25303.
   PubMed Web of Science ®Google Scholar
• Teruel-Montoya R, Kong X, Abraham S, Ma L, Kunapuli SP, Holinstat M, Shaw CA, McKenzie SE, Edelstein LC, Bray PF. MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression. PLoS One 2014;9:e102259. doi:10.1371/journal.pone.0102259.
   PubMedGoogle Scholar
• Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;16:961–966. doi:10.1038/nsmb.1651.
   PubMed Web of Science ®Google Scholar
• Girardot M, Pecquet C, Boukour S, Knoops L, Ferrant A, Vainchenker W, Giraudier S, Constantinescu SN. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood 2010;116:437–445. doi:10.1182/blood-2008-06-165985.
   PubMed Web of Science ®Google Scholar
• Arroyo AB, de Los Reyes-Garcia AM, Teruel-Montoya R, Vicente V, Gonzalez-Conejero R, Martinez C. microRNAs in the haemostatic system: more than witnesses of thromboembolic diseases? Thromb Res 2018;166:1–9. doi:10.1016/j.thromres.2018.03.021.
   PubMed Web of Science ®Google Scholar
• Navarro A, Pairet S, Alvarez-Larran A, Pons A, Ferrer G, Longarón R, Fernández-Rodríguez C, Camacho L, Monzó M, Besses C, et al. miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia. Blood Cancer J 2016;6:e406. doi:10.1038/bcj.2016.10.
   PubMed Web of Science ®Google Scholar
• Tombak A, Ay OI, Erdal ME, Sungur MA, Ucar MA, Akdeniz A, Tiftik EN. MicroRNA expression analysis in patients with primary myelofibrosis, polycythemia vera and essential thrombocythemia. Indian J Hematol Blood Transfus 2015;31:416–425. doi:10.1007/s12288-014-0492-z.
   PubMed Web of Science ®Google Scholar
• Xu X, Gnatenko DV, Ju J, Hitchcock IS, Martin DW, Zhu W, Bahou WF. Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood 2012;120:3575–3585. doi:10.1182/blood-2012-02-411264.
   PubMed Web of Science ®Google Scholar
• Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol 2008;143:570–580. doi:10.1111/j.1365-2141.2008.07382.x.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ran Y, Shaw TS, Peng Y. MicroRNAs 10a and 10b regulate the expression of human platelet glycoprotein ibalpha for normal megakaryopoiesis. Int J Mol Sci. 2016;17. doi:10.3390/ijms17111873.
   Web of Science ®Google Scholar
• Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q, Whiteheart SW, Shaw C, et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 2010;8:369–378. doi:10.1111/j.1538-7836.2009.03700.x.
   PubMed Web of Science ®Google Scholar
• Kaudewitz D, Skroblin P, Bender LH, Barwari T, Willeit P, Pechlaner R, Sunderland NP, Willeit K, Morton AC, Armstrong PC, et al. Association of MicroRNAs and YRNAs with platelet function. Circ Res 2016;118:420–432. doi:10.1161/CIRCRESAHA.114.305663.
   PubMed Web of Science ®Google Scholar
• Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008;14:843–853. doi:10.1016/j.devcel.2008.03.012.
   PubMed Web of Science ®Google Scholar
• Pedersen OH, Larsen ML, Grove EL, van Kooten Niekerk PB, Bønløkke S, Nissen PH, Kristensen SD, Hvas A-M. Platelet characteristics in patients with essential thrombocytosis. Cytometry B Clin Cytom 2018;94:918–927. doi:10.1002/cyto.b.21642.
   PubMed Web of Science ®Google Scholar
• Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Colomer D, Villamor N, Bellosillo B, Cervantes F. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. Am J Hematol 2009;84:102–108. doi:10.1002/ajh.21338.
   PubMed Web of Science ®Google Scholar
• Freynhofer MK, Gruber SC, Grove EL, Weiss TW, Wojta J, Huber K. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. Thromb Haemost 2015;114:459–468. doi:10.1160/TH15-02-0179.
   PubMed Web of Science ®Google Scholar
• Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245–5250. doi:10.1158/0008-5472.CAN-04-0496.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method.Nat Protoc 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–622. doi:10.1373/clinchem.2008.112797.
   PubMed Web of Science ®Google Scholar
• Hvas AM, Grove EL. Platelet function tests: preanalytical variables, clinical utility, advantages, and disadvantages. Methods Mol Biol 2017;1646:305–320. doi:10.1007/978-1-4939-7196-1_24.
   PubMedGoogle Scholar
• Rubak P, Nissen PH, Kristensen SD, Hvas AM. Investigation of platelet function and platelet disorders using flow cytometry. Platelets 2016;27:66–74. doi:10.3109/09537104.2015.1032919.
   PubMed Web of Science ®Google Scholar
• Pedersen OH, Nissen PH, Hvas AM. Platelet function investigation by flow cytometry: sample volume, needle size, and reference intervals. Platelets 2018;29:199–202. doi:10.1080/09537104.2017.1353684.
   PubMed Web of Science ®Google Scholar
• Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, et al. MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A 2008;73:926–930. doi:10.1002/cyto.a.20623.
   PubMed Web of Science ®Google Scholar
• Liu R, Ma X, Xu L, Wang D, Jiang X, Zhu W, Cui B, Ning G, Lin D, Wang S. Differential microRNA expression in peripheral blood mononuclear cells from Graves’ disease patients. J Clin Endocrinol Metab 2012;97:E968–72. doi:10.1210/jc.2011-2982.
   PubMed Web of Science ®Google Scholar
• Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3ʹ untranslated region. Oncogene 2010;29:2302–2308. doi:10.1038/onc.2010.34.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Akiyama Y, Yuasa Y. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One 2013;8:e62589. doi:10.1371/journal.pone.0062589.
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, et al. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.Blood 1997;90:4031–4038.
   PubMed Web of Science ®Google Scholar
• Raghuwanshi S, Dahariya S, Musvi SS, Gutti U, Kandi R, Undi RB, Sahu I, Gautam DK, Paddibhatla I, Gutti RK. MicroRNA function in megakaryocytes. Platelets 2018;1–8. doi:10.1080/09537104.2018.1528343.
   PubMed Web of Science ®Google Scholar
• Raghuwanshi S, Gutti U, Kandi R, Gutti RK. MicroRNA-9 promotes cell proliferation by regulating RUNX1 expression in human megakaryocyte development. Cell Prolif 2018;51. doi:10.1111/cpr.12414. Epub 2017 Nov 28.
   Web of Science ®Google Scholar
• Ferrer-Marin F, Gutti R, Liu ZJ, Sola-Visner M. MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes. J Thromb Haemost 2014;12:282–285. doi:10.1111/jth.12469.
   Web of Science ®Google Scholar
• Zhan H, Cardozo C, Raza A. MicroRNAs in myeloproliferative neoplasms. Br J Haematol 2013;161:471–483. doi:10.1111/bjh.12276.
   PubMed Web of Science ®Google Scholar
• Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007;35:1657–1667. doi:10.1016/j.exphem.2007.08.021.
   PubMed Web of Science ®Google Scholar
• Bruchova H, Merkerova M, Prchal JT. Aberrant expression of microRNA in polycythemia vera. Haematologica 2008;93:1009–1016. doi:10.3324/haematol.12706.
   PubMed Web of Science ®Google Scholar
• Barroga CF, Pham H, Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol 2008;36:1585–1592. doi:10.1016/j.exphem.2008.07.001.
   PubMed Web of Science ®Google Scholar
• Shi R, Ge L, Zhou X, Ji WJ, Lu RY, Zhang YY, Zeng S, Liu X, Zhao JH, Zhang WC, Jiang TM, Li YM. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res 2013;131:508–513. doi:10.1016/j.thromres.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wu S, Huang E, Gnatenko D, Bahou WF, Zhu W. Integrated micro/messenger RNA regulatory networks in essential thrombocytosis. PLoS One 2018;13:e0191932. doi:10.1371/journal.pone.0191932.
   PubMed Web of Science ®Google Scholar
• Panova-Noeva M, Marchetti M, Buoro S, Russo L, Leuzzi A, Finazzi G, Rambaldi A, Ottomano C, Ten Cate H, Falanga A. JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients. Blood 2011;118:2599–2601. doi:10.1182/blood-2011-02-339655.
   PubMed Web of Science ®Google Scholar
• Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi ML. Thrombotic risk correlates with mutational status in true essential thrombocythemia. Eur J Clin Invest 2016;46:683–689. doi:10.1111/eci.12647.
   PubMed Web of Science ®Google Scholar
• Li S, Guo LZ, Kim MH, Han JY, Serebruany V. Platelet microRNA for predicting acute myocardial infarction. J Thromb Thrombolysis 2017;44:556–564. doi:10.1007/s11239-017-1537-6.
   PubMed Web of Science ®Google Scholar
• Maues JHDS, Moreira-Nunes CFA, Pontes TB, Vieira PCM, Montenegro RC, Lamarão LM, Lima EM, Burbano RMR. Differential expression profile of MicroRNAs during prolonged storage of platelet concentrates as a quality measurement tool in blood banks. OMICS 2018;22:653–664. doi:10.1089/omi.2018.0126.
   PubMed Web of Science ®Google Scholar